Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Nuwellis Inc (NUWE) – Nuwellis Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Nuwellis (NUWE) trades at $1.03, down 0.96% on the day, reflecting ongoing financial challenges despite recent business developments. The company reported a significant net loss margin of -211.86% for 2025, with negative cash flow, though it maintains a strong gross margin of 61.96%. Recent news highlights clinical advancements in pediatric cardiorenal care and a strategic acquisition, but fundamental profitability remains a primary concern for investors.
The outlook is mixed, with potential growth from expanded pediatric applications and new patents, but substantial execution risk exists due to persistent losses and negative shareholder equity. Analyst coverage is limited but evenly split between Buy and Hold ratings, indicating cautious optimism contingent on the company's ability to translate its medical technology into sustainable financial performance.
Read full analysis

Key Stats

  • Market Cap
    $2.71M
  • Sector
    Technology
  • 3M Drawdown
    -45.99%
  • Enterprise Value
    $1.96M
  • Dividend Yield
    -
  • Trading Activity
    28% Buy | 72% Sell
  • Typical Hold Time
    5 days
$1.08
52W Low: $1.01
19 Mar 2026
52W High: $40.51
14 May 2025

Nuwellis Inc (NUWE) is currently valued at a market capitalization of $2.71M, with an enterprise value of $1.96M. Over the past 52 weeks, Nuwellis Inc has traded between a low of $1.01 and a high of $40.51, highlighting its annual price range. Over the past three months, Nuwellis Inc has recorded a drawdown of -45.99%, reflecting recent price volatility. On average, investors hold Nuwellis Inc for approximately 5 days, indicating typical investor behavior on the platform.

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.


Technical Indicators
|
|
|
Overall Summary
Bearish (14)Neutral (11)Bullish (0)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $2.71M
  • Sector
    Technology
  • 3M Drawdown
    -45.99%
  • Enterprise Value
    $1.96M
  • Dividend Yield
    -
  • Trading Activity
    28% Buy | 72% Sell
  • Typical Hold Time
    5 days
$1.08
52W Low: $1.01
19 Mar 2026
52W High: $40.51
14 May 2025

Nuwellis Inc (NUWE) is currently valued at a market capitalization of $2.71M, with an enterprise value of $1.96M. Over the past 52 weeks, Nuwellis Inc has traded between a low of $1.01 and a high of $40.51, highlighting its annual price range. Over the past three months, Nuwellis Inc has recorded a drawdown of -45.99%, reflecting recent price volatility. On average, investors hold Nuwellis Inc for approximately 5 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!